Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

On changes in cancer mortality among HIV-infected patients: is there an excess risk of death from pancreatic cancer?

Serraino D, Dal Maso L, De Paoli A, Zucchetto A, Bruzzone S, Camoni L, Suligoi B.

Clin Infect Dis. 2009 Aug 1;49(3):481-2. doi: 10.1086/600823. No abstract available.

PMID:
19586399
2.

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

Meignan M, Gallamini A, Meignan M, Gallamini A, Haioun C.

Leuk Lymphoma. 2009 Aug;50(8):1257-60. doi: 10.1080/10428190903040048.

PMID:
19544140
3.

High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors.

Re A, Michieli M, Casari S, Allione B, Cattaneo C, Rupolo M, Spina M, Manuele R, Vaccher E, Mazzucato M, Abbruzzese L, Ferremi P, Carosi G, Tirelli U, Rossi G.

Blood. 2009 Aug 13;114(7):1306-13. doi: 10.1182/blood-2009-02-202762. Epub 2009 May 18.

4.

Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.

Itti E, Lin C, Dupuis J, Paone G, Capacchione D, Rahmouni A, Haioun C, Meignan M.

J Nucl Med. 2009 Apr;50(4):527-33. doi: 10.2967/jnumed.108.057703. Epub 2009 Mar 16.

5.

Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey.

Bonnet F, Burty C, Lewden C, Costagliola D, May T, Bouteloup V, Rosenthal E, Jougla E, Cacoub P, Salmon D, Chêne G, Morlat P; Agence Nationale de Recherches sur le Sida et les Hépatites Virales EN19 Mortalité Study Group.; Mortavic Study Group..

Clin Infect Dis. 2009 Mar 1;48(5):633-9.

PMID:
19202627
6.

Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Møller H, Bower M.

J Clin Oncol. 2009 Feb 20;27(6):884-90. doi: 10.1200/JCO.2008.19.6626. Epub 2008 Dec 29.

PMID:
19114688
7.

18F-fluorodeoxyglucose positron emission tomography/computed tomography in AIDS-related Burkitt lymphoma.

Just PA, Fieschi C, Baillet G, Galicier L, Oksenhendler E, Moretti JL.

AIDS Patient Care STDS. 2008 Sep;22(9):695-700. doi: 10.1089/apc.2008.0174.

PMID:
18793085
8.

PET/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loads.

Goshen E, Davidson T, Avigdor A, Zwas TS, Levy I.

Clin Nucl Med. 2008 Sep;33(9):610-4. doi: 10.1097/RLU.0b013e3181813047.

PMID:
18716509
9.

The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype.

Vockerodt M, Morgan SL, Kuo M, Wei W, Chukwuma MB, Arrand JR, Kube D, Gordon J, Young LS, Woodman CB, Murray PG.

J Pathol. 2008 Sep;216(1):83-92. doi: 10.1002/path.2384.

PMID:
18566961
10.

EBV-associated lymphoproliferative disorders: classification and treatment.

Carbone A, Gloghini A, Dotti G.

Oncologist. 2008 May;13(5):577-85. doi: 10.1634/theoncologist.2008-0036. Review.

11.

Cancer risk in people infected with human immunodeficiency virus in the United States.

Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ.

Int J Cancer. 2008 Jul 1;123(1):187-94. doi: 10.1002/ijc.23487.

12.

Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy.

Berenguer J, Miralles P, Ribera JM, Rubio R, Valencia E, Mahillo B, Pintado V, Palacios R, Montes ML, Téllez MJ, La Cruz J, Torre-Cisneros J, Rodríguez-Arrondo F, Sepúlveda MA, Gutiérrez F, Peralta G, Boix V.

J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):422-8.

PMID:
18434957
13.

Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020.

Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ, Aboulafia DM, Scadden DT.

Biol Blood Marrow Transplant. 2008 Jan;14(1):59-66.

14.

Germinal centres: role in B-cell physiology and malignancy.

Klein U, Dalla-Favera R.

Nat Rev Immunol. 2008 Jan;8(1):22-33. Review.

PMID:
18097447
15.

HIV infection and lymphoma.

Grogg KL, Miller RF, Dogan A.

J Clin Pathol. 2007 Dec;60(12):1365-72. Review.

16.

Response to highly active antiretroviral therapy as the only therapy in an HIV-infected patient with interfollicular Hodgkin's lymphoma.

Xicoy B, Ribera JM, Romeu J, Mate JL, Millà F, Feliu E.

Leuk Lymphoma. 2007 Oct;48(10):2058-9. No abstract available.

PMID:
17917974
17.

Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe.

Serraino D, Piselli P, Busnach G, Burra P, Citterio F, Arbustini E, Baccarani U, De Juli E, Pozzetto U, Bellelli S, Polesel J, Pradier C, Dal Maso L, Angeletti C, Carrieri MP, Rezza G, Franceschi S; Immunosuppression and Cancer Study Group..

Eur J Cancer. 2007 Sep;43(14):2117-23. Epub 2007 Aug 30.

PMID:
17764927
18.

Epstein-Barr virus-associated lymphoproliferative disorders.

Rezk SA, Weiss LM.

Hum Pathol. 2007 Sep;38(9):1293-304. Review.

19.

HIV-associated Hodgkin's lymphoma. Antiapoptotic pathways and mechanisms for immune escape by tumor cells in the setting of improved immunity.

Carbone A, Cabras A, Gloghini A.

Int J Biol Markers. 2007 Apr-Jun;22(2):161-3. No abstract available.

PMID:
17549673
20.

Immunodeficiency-related Hodgkin lymphoma and its mimics.

Said JW.

Adv Anat Pathol. 2007 May;14(3):189-94. Review.

PMID:
17452815

Supplemental Content

Support Center